The Board of Regents of The University of Texas System
发明人:
申请号：
EP17748334.4
公开号：
EP3411070A4
申请日:
2017.02.06
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
Isolated or recombinant anti-EGFL6 monoclonal antibodies are provided. In some cases, antibodies of the embodiments can be used for the detection, diagnosis and/or therapeutic treatment of human diseases, such as cancer.
